Bevacizumab/Irinotecan
CRCST-L-0006
Phase 2 small_molecule completed
Quick answer
Bevacizumab/Irinotecan for Glioblastoma is a Phase 2 program (small_molecule) at Solid Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Glioblastoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed